Clinical Scorecard: What's New in DED in 2026?
At a Glance
| Category | Detail |
|---|---|
| Condition | Dry Eye Disease (DED) |
| Key Mechanisms | Identification of root causes through a stepped approach. |
| Target Population | Patients with dry eye disease. |
| Care Setting | Optometry and ophthalmology clinics. |
Key Highlights
- TFOS DEWS III provides a step-by-step approach to diagnosing DED.
- New medications targeting specific root causes of DED are emerging.
- Focus on individualized patient assessment to determine treatment.
Guideline-Based Recommendations
Diagnosis
- Utilize the TFOS DEWS III step approach to identify root causes.
Management
- Implement new medications tailored to specific causes of DED.
Monitoring & Follow-up
- Regularly assess patient response to new treatments.
Risks
- Consider potential side effects of new medications.
Patient & Prescribing Data
Individuals diagnosed with dry eye disease.
Emphasis on personalized treatment based on root cause analysis.
Clinical Best Practices
- Adopt the TFOS DEWS III guidelines for comprehensive patient evaluation.
- Stay updated on emerging therapies for DED.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.